A comprehensive molecular docking analysis was conducted to characterize the binding interactions between selected natural compounds and three pivotal protein targets implicated in neurodevelopmental disorders: CSNK2B (PDB ID 3EED), GRIN1 (PDB ID 5H8H), and MAPK1 (PDB ID 6SLG). This evidence concerns the gene MAPK1 and neurodevelopmental disorder.